French precision-fermented protein start-up Standing Ovation has raised €3.75 million in a Series A+ funding round.

The start-up has developed a solution to produce casein and begin sales of its patented ingredient, Advanced Casein, positioning itself as a global player in the food transition.

Backed by Standing Ovation's existing shareholders, the €3.75 million Series A+ round is set to accelerate the company's growth and sales of its flagship protein, Advanced Casein. The company plans to complete preparations for industrial-scale production by the end of the year.

Advanced Casein emits 10 times less CO2 than animal-derived milk proteins, enables efficient use of water and land and is free from antibiotics and GMO traces – all while ensuring consumers the same nutritional, functional and taste qualities as protein originating from livestock.

Standing Ovation previously raised €12 million in 2022 through a Series A round led by Astanor Ventures, with backing from Bel Group. The latest Series A+ round brings the total funds raised in four years to €23 million.

Standing Ovation has also announced the appointment of a new CEO, Yvan Chardonnens. With 30 years of experience in growing global B2B companies, Standing Ovation expects Chardonnens’ appointment to help ramp up its production at an industrial scale.

Before joining Standing Ovation, Chardonnens’ was chief commercial officer at Oterra, one of the world's largest suppliers of natural colourants for the food industry. He previously held roles at Firmenich, International Flavors & Fragrances (IFF), Barry Callebaut and Roquette.

New CEO Chardonnens commented: “I am excited to be joining such an innovative company at the forefront of its sector, with the potential to have a positive impact on our food ecosystems and deliver solutions to climate challenges. In just four years under Romain's leadership, Standing Ovation has hit key technological, operational and financial milestones, paving the way for the next phase of industrial-scale growth. Together, our priority will be to step up our development by obtaining the necessary regulatory approval, strengthening our go-to-market strategy and embarking on large-scale industrial production.”

Romain Chayot, co-founder and managing director of Standing Ovation, added: “After four years of research and innovation to fine-tune our industrial manufacturing and production process, the time has come to accelerate towards mass production and distribution of Advanced Casein in the global agrifood market. Chardonnens has a reputation as a pioneer in developing new products that meet both industrial challenges and consumer demand. Our respective areas of expertise are a perfect fit and will enable Standing Ovation to become the global leader in alternative proteins and a key player in the food transition.”

#StandingOvation #France #precisionfermentation #casein